Chemistry:Eticyclidine
![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
Chemical and physical data | |
Formula | C14H21N |
Molar mass | 203.329 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Eticyclidine (PCE, CI-400) is a dissociative anesthetic drug with hallucinogenic effects. It is similar in effects to phencyclidine but is slightly more potent. PCE was developed by Parke-Davis in the 1970s and evaluated for anesthetic potential under the code name CI-400,[1] but research into PCE was not continued after the development of ketamine, a similar drug with more favourable properties.[2] PCE is slightly more potent than PCP and has similar effects, but its unpleasant taste and tendency to cause nausea made it less accepted by users.[citation needed] Due to its similarity in effects to PCP, PCE was placed into the Schedule 1 list of illegal drugs in the 1970s, although it was only briefly abused in the 1970s and 1980s and is now little known.
See also
References
- ↑ "Observation on two psychotomimetic drugs of piperidine derivation--CI 395 (sernyl) and CI 400". The American Journal of Psychiatry 116 (9): 843–4. March 1960. doi:10.1176/ajp.116.9.843. PMID 14416411.
- ↑ "1-Phenycycloalkylamine derivatives. II. Synthesis and pharmacological activity". Journal of Medicinal Chemistry 12 (3): 473–7. May 1969. doi:10.1021/jm00303a030. PMID 4977945.
Inhalational | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Injection |
| ||||||||||||
|
D1-like |
| ||||
---|---|---|---|---|---|
D2-like |
| ||||
AMPAR |
|
---|---|
KAR |
|
NMDAR |
|
![]() | 0.00 ![]() ![]() ![]() ![]() ![]() |